Last Posted: Sep-29-2023 06:34:03

Distinguishing features of Long COVID identified through immune profiling.
Jon Klein et al. Nature 2023 9
A molnupiravir-associated mutational signature in global SARS-CoV-2 genomes.
Theo Sanderson et al. Nature 2023 9
Engaging a national-scale cohort of smart thermometer users in participatory surveillance
YJ Tseng et al, NPJ Digital Medicine, September 20, 2023
Updated COVID-19 Vaccine Now Available in US, Recommended for Everyone Older Than 6 Months
R Rubin, JAMA, September 18, 2023

Bakaros Evangelos, et al. Viruses 2023 0 0. (9)
Evaluation of a Commercial Point-of-Care RT-LAMP Assay for Rapid Detection of SARS-CoV-2.
Law Janet Hei Yin, et al. Biomedicines 2023 0 0. (9)
Riding the Omicron BA.5 Wave: Improved Humoral Response after Vaccination with Bivalent Omicron BA.4-5-Adapted mRNA SARS-CoV-2 Vaccine in Chronic Hemodialysis Patients.
Ovcar Eugen, et al. Vaccines 2023 0 0. (9)
Gene Polymorphisms of Epithelial Cell-Derived Alarmins and Their Effects on Protein Levels and Disease Severity in Patients with COVID-19.
Ranjbar Maral, et al. Genes 2023 0 0. (9)
Integration of Omics Data and Network Models to Unveil Negative Aspects of SARS-CoV-2, from Pathogenic Mechanisms to Drug Repurposing.
Bernardo Letizia, et al. Biology 2023 0 0. (9)
Effectiveness of Mix-and-Match Vaccination in Preventing SARS-CoV-2 Omicron Variant Infection in Taiwan: A Test-Negative Control Study.
Huang Yu-Tung, et al. Vaccines 2023 0 0. (9)
The Rise and Fall of Omicron BA.1 Variant as Seen in Wastewater Supports Epidemiological Model Predictions.
Liddor Naim Michal, et al. Viruses 2023 0 0. (9)
Polymorphisms within the SARS-CoV-2 Human Receptor Genes Associate with Variable Disease Outcomes across Ethnicities.
Adimulam Theolan, et al. Genes 2023 0 0. (9)
Genomic Epidemiology and Lineage Dynamics of SARS-CoV-2 in Bulgaria: Insights from a Three-Year Pandemic Analysis.
Giovanetti Marta, et al. Viruses 2023 0 0. (9)
From Alpha to Omicron: How Different Variants of Concern of the SARS-Coronavirus-2 Impacted the World.
Andre Mickensone, et al. Biology 2023 0 0. (9)
All Latest
About COVID-19 GPH
Site Citation:
Wei Yu, et al. COVID-19 GPH: tracking the contribution of genomics and precision health to the COVID-19 pandemic response. BMC Infectious Diseases (2022) 22:402.


Special Topics
In PHGKB Databases
Genomics Precision Health (GPH): The use of pathogen and human genomics and advanced molecular detection methods in discovery, clinical and public health investigations and response to COVID-19.
Non Genomics Precision Health (non-GPH): The use of big data, data science, digital health, machine learning and predictive analytic methods (not involving genomics) in discovery, clinical and public health investigations and response to COVID-19
Following categories are annotated by LitCovid from NCBI NIH.
Mechanism | Underlying cause(s) of covid-19 infections and transmission & possible drug mechanism of action |
Transmission | Characteristics and modes of covid-19 transmissions, such as human-to-human |
Diagnosis | Disease assessment through symptoms, test results, and radiological features |
Prevention | Prevention, control, response and management strategies |
Case Report | Descriptions of specific patient cases |
Forecasting | Modelling and estimating the trend of covid-19 spread |
Health Equity | Relevant to health equity. Search terms are derived from a list provided by the Association for Territorial Health Officials which include terms such as diversity, health disparities, and others. |
Vaccine | Relevant to vaccine development, evaluation, implementation and impact. For additional information on vaccines and COVID-19. Check out general CDC Information pages |
Variant | Relevant to SARS-CoV-2 variants and their impact on public health. For additional information on variants COVID-19. Check out CDC New Variants of the Virus that Causes COVID-19 page |
Surveillance | Relevant to SARS-CoV-2 public health surveillance and tracking. For additional information on COVID-19 surveillance, check out CDC COVID-19 Data Tracker |
Wei Yu, Emily Drzymalla, Marta Gwinn and Muin J. Khoury. COVID-19 GPH: tracking the contribution of genomics and precision health to the COVID-19 pandemic response. BMC Infectious Diseases (2022) 22:402.
Disclaimer: Articles listed in the Public Health Genomics and Precision Health Knowledge Base are selected by the CDC Office of Genomics and Precision Public Health to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2023
- Page last updated:Sep 29, 2023
- Content source: